カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ホルモン補充用医薬品のグローバル市場展望 2023年-2029年：エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン

■ 英語タイトル：Drugs For Hormonal Replacement Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8493）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8493
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ホルモン補充用医薬品のグローバル市場展望 2023年-2029年：エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のホルモン補充用医薬品市場規模と予測を収録しています。・世界のホルモン補充用医薬品市場：売上、2018年-2023年、2024年-2029年
・世界のホルモン補充用医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のホルモン補充用医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「エストロゲンホルモン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ホルモン補充用医薬品のグローバル主要企業は、Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ホルモン補充用医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のホルモン補充用医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界のホルモン補充用医薬品市場：タイプ別市場シェア、2022年
・エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン

世界のホルモン補充用医薬品市場：用途別、2018年-2023年、2024年-2029年
世界のホルモン補充用医薬品市場：用途別市場シェア、2022年
・更年期障害、甲状腺機能低下症、成長ホルモン欠乏症、男性生殖機能不全、その他の疾患

世界のホルモン補充用医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界のホルモン補充用医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるホルモン補充用医薬品のグローバル売上、2018年-2023年
・主要企業におけるホルモン補充用医薬品のグローバル売上シェア、2022年
・主要企業におけるホルモン補充用医薬品のグローバル販売量、2018年-2023年
・主要企業におけるホルモン補充用医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD

*************************************************************

・調査・分析レポートの概要
ホルモン補充用医薬品市場の定義
市場セグメント
世界のホルモン補充用医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のホルモン補充用医薬品市場規模
世界のホルモン補充用医薬品市場規模：2022年 VS 2029年
世界のホルモン補充用医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのホルモン補充用医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のホルモン補充用医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン
ホルモン補充用医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：更年期障害、甲状腺機能低下症、成長ホルモン欠乏症、男性生殖機能不全、その他の疾患
ホルモン補充用医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別ホルモン補充用医薬品市場規模 2022年と2029年
地域別ホルモン補充用医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD
...

Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
This report aims to provide a comprehensive presentation of the global market for Drugs For Hormonal Replacement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs For Hormonal Replacement. This report contains market size and forecasts of Drugs For Hormonal Replacement in global, including the following market information:
Global Drugs For Hormonal Replacement Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs For Hormonal Replacement Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Drugs For Hormonal Replacement companies in 2022 (%)
The global Drugs For Hormonal Replacement market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Estrogen Hormone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs For Hormonal Replacement include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs For Hormonal Replacement manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs For Hormonal Replacement Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, by Type, 2022 (%)
Estrogen Hormone
Growth Hormone
Thyroid Hormone
Testosterone Hormone
Global Drugs For Hormonal Replacement Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, by Application, 2022 (%)
Menopause
Hypothyroidism
Growth Hormone Deficiency
Male Hypogonadism
Other Diseases
Global Drugs For Hormonal Replacement Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Drugs For Hormonal Replacement Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs For Hormonal Replacement revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs For Hormonal Replacement revenues share in global market, 2022 (%)
Key companies Drugs For Hormonal Replacement sales in global market, 2018-2023 (Estimated), (Units)
Key companies Drugs For Hormonal Replacement sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs For Hormonal Replacement, market overview.
Chapter 2: Global Drugs For Hormonal Replacement market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs For Hormonal Replacement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs For Hormonal Replacement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs For Hormonal Replacement capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Drugs For Hormonal Replacement Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs For Hormonal Replacement Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs For Hormonal Replacement Overall Market Size
2.1 Global Drugs For Hormonal Replacement Market Size: 2022 VS 2029
2.2 Global Drugs For Hormonal Replacement Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs For Hormonal Replacement Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs For Hormonal Replacement Players in Global Market
3.2 Top Global Drugs For Hormonal Replacement Companies Ranked by Revenue
3.3 Global Drugs For Hormonal Replacement Revenue by Companies
3.4 Global Drugs For Hormonal Replacement Sales by Companies
3.5 Global Drugs For Hormonal Replacement Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs For Hormonal Replacement Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs For Hormonal Replacement Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs For Hormonal Replacement Players in Global Market
3.8.1 List of Global Tier 1 Drugs For Hormonal Replacement Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs For Hormonal Replacement Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs For Hormonal Replacement Market Size Markets, 2022 & 2029
4.1.2 Estrogen Hormone
4.1.3 Growth Hormone
4.1.4 Thyroid Hormone
4.1.5 Testosterone Hormone
4.2 By Type – Global Drugs For Hormonal Replacement Revenue & Forecasts
4.2.1 By Type – Global Drugs For Hormonal Replacement Revenue, 2018-2023
4.2.2 By Type – Global Drugs For Hormonal Replacement Revenue, 2024-2029
4.2.3 By Type – Global Drugs For Hormonal Replacement Revenue Market Share, 2018-2029
4.3 By Type – Global Drugs For Hormonal Replacement Sales & Forecasts
4.3.1 By Type – Global Drugs For Hormonal Replacement Sales, 2018-2023
4.3.2 By Type – Global Drugs For Hormonal Replacement Sales, 2024-2029
4.3.3 By Type – Global Drugs For Hormonal Replacement Sales Market Share, 2018-2029
4.4 By Type – Global Drugs For Hormonal Replacement Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs For Hormonal Replacement Market Size, 2022 & 2029
5.1.2 Menopause
5.1.3 Hypothyroidism
5.1.4 Growth Hormone Deficiency
5.1.5 Male Hypogonadism
5.1.6 Other Diseases
5.2 By Application – Global Drugs For Hormonal Replacement Revenue & Forecasts
5.2.1 By Application – Global Drugs For Hormonal Replacement Revenue, 2018-2023
5.2.2 By Application – Global Drugs For Hormonal Replacement Revenue, 2024-2029
5.2.3 By Application – Global Drugs For Hormonal Replacement Revenue Market Share, 2018-2029
5.3 By Application – Global Drugs For Hormonal Replacement Sales & Forecasts
5.3.1 By Application – Global Drugs For Hormonal Replacement Sales, 2018-2023
5.3.2 By Application – Global Drugs For Hormonal Replacement Sales, 2024-2029
5.3.3 By Application – Global Drugs For Hormonal Replacement Sales Market Share, 2018-2029
5.4 By Application – Global Drugs For Hormonal Replacement Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs For Hormonal Replacement Market Size, 2022 & 2029
6.2 By Region – Global Drugs For Hormonal Replacement Revenue & Forecasts
6.2.1 By Region – Global Drugs For Hormonal Replacement Revenue, 2018-2023
6.2.2 By Region – Global Drugs For Hormonal Replacement Revenue, 2024-2029
6.2.3 By Region – Global Drugs For Hormonal Replacement Revenue Market Share, 2018-2029
6.3 By Region – Global Drugs For Hormonal Replacement Sales & Forecasts
6.3.1 By Region – Global Drugs For Hormonal Replacement Sales, 2018-2023
6.3.2 By Region – Global Drugs For Hormonal Replacement Sales, 2024-2029
6.3.3 By Region – Global Drugs For Hormonal Replacement Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drugs For Hormonal Replacement Revenue, 2018-2029
6.4.2 By Country – North America Drugs For Hormonal Replacement Sales, 2018-2029
6.4.3 US Drugs For Hormonal Replacement Market Size, 2018-2029
6.4.4 Canada Drugs For Hormonal Replacement Market Size, 2018-2029
6.4.5 Mexico Drugs For Hormonal Replacement Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drugs For Hormonal Replacement Revenue, 2018-2029
6.5.2 By Country – Europe Drugs For Hormonal Replacement Sales, 2018-2029
6.5.3 Germany Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.4 France Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.5 U.K. Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.6 Italy Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.7 Russia Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.8 Nordic Countries Drugs For Hormonal Replacement Market Size, 2018-2029
6.5.9 Benelux Drugs For Hormonal Replacement Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drugs For Hormonal Replacement Revenue, 2018-2029
6.6.2 By Region – Asia Drugs For Hormonal Replacement Sales, 2018-2029
6.6.3 China Drugs For Hormonal Replacement Market Size, 2018-2029
6.6.4 Japan Drugs For Hormonal Replacement Market Size, 2018-2029
6.6.5 South Korea Drugs For Hormonal Replacement Market Size, 2018-2029
6.6.6 Southeast Asia Drugs For Hormonal Replacement Market Size, 2018-2029
6.6.7 India Drugs For Hormonal Replacement Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drugs For Hormonal Replacement Revenue, 2018-2029
6.7.2 By Country – South America Drugs For Hormonal Replacement Sales, 2018-2029
6.7.3 Brazil Drugs For Hormonal Replacement Market Size, 2018-2029
6.7.4 Argentina Drugs For Hormonal Replacement Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drugs For Hormonal Replacement Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drugs For Hormonal Replacement Sales, 2018-2029
6.8.3 Turkey Drugs For Hormonal Replacement Market Size, 2018-2029
6.8.4 Israel Drugs For Hormonal Replacement Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs For Hormonal Replacement Market Size, 2018-2029
6.8.6 UAE Drugs For Hormonal Replacement Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Drugs For Hormonal Replacement Major Product Offerings
7.1.4 Eli Lilly Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs For Hormonal Replacement Major Product Offerings
7.2.4 Pfizer Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Drugs For Hormonal Replacement Major Product Offerings
7.3.4 AbbVie Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Drugs For Hormonal Replacement Major Product Offerings
7.4.4 Novo Nordisk Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Drugs For Hormonal Replacement Major Product Offerings
7.5.4 Merck KGaA Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Drugs For Hormonal Replacement Major Product Offerings
7.6.4 Mylan Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Drugs For Hormonal Replacement Major Product Offerings
7.7.4 Bayer Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Drugs For Hormonal Replacement Major Product Offerings
7.8.4 Teva Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Drugs For Hormonal Replacement Major Product Offerings
7.9.4 Novartis Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Drugs For Hormonal Replacement Major Product Offerings
7.10.4 Abbott Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Drugs For Hormonal Replacement Business Overview
7.11.3 Roche Drugs For Hormonal Replacement Major Product Offerings
7.11.4 Roche Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Drugs For Hormonal Replacement Business Overview
7.12.3 Endo International Drugs For Hormonal Replacement Major Product Offerings
7.12.4 Endo International Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Ipsen
7.13.1 Ipsen Company Summary
7.13.2 Ipsen Drugs For Hormonal Replacement Business Overview
7.13.3 Ipsen Drugs For Hormonal Replacement Major Product Offerings
7.13.4 Ipsen Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.13.5 Ipsen Key News & Latest Developments
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Company Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Drugs For Hormonal Replacement Major Product Offerings
7.14.4 ANI Pharmaceuticals Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.14.5 ANI Pharmaceuticals Key News & Latest Developments
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Company Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Drugs For Hormonal Replacement Major Product Offerings
7.15.4 TherapeuticsMD Drugs For Hormonal Replacement Sales and Revenue in Global (2018-2023)
7.15.5 TherapeuticsMD Key News & Latest Developments
8 Global Drugs For Hormonal Replacement Production Capacity, Analysis
8.1 Global Drugs For Hormonal Replacement Production Capacity, 2018-2029
8.2 Drugs For Hormonal Replacement Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs For Hormonal Replacement Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs For Hormonal Replacement Supply Chain Analysis
10.1 Drugs For Hormonal Replacement Industry Value Chain
10.2 Drugs For Hormonal Replacement Upstream Market
10.3 Drugs For Hormonal Replacement Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs For Hormonal Replacement Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 腎代替療法のグローバル市場展望 2023年-2029年：デバイス、消耗品、サービス
  • 腎代替療法のグローバル市場展望 2023年-2029年：機器、ダイアライザー、その他消耗品、サービス
  • 経カテーテル僧帽弁修復置換術（TMVR）のグローバル市場展望 2023年-2029年：修繕、交換
  • イロプロスト薬のグローバル市場展望 2023年-2029年：吸入型、静脈内型
  • うつ病治療薬のグローバル市場展望 2023年-2029年：SSRI、SNRI、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8493 )"ホルモン補充用医薬品のグローバル市場展望 2023年-2029年：エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン" (英文：Drugs For Hormonal Replacement Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。